Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| RNA, Bacterial | 1 | 2018 | 116 | 0.72 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.57 | Why? |
| Pneumonia, Bacterial | 1 | 2018 | 843 | 0.44 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.38 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 1645 | 0.38 | Why? |
| Cystic Fibrosis | 1 | 2018 | 1104 | 0.36 | Why? |
| New York City | 7 | 2021 | 7432 | 0.30 | Why? |
| Systemic Inflammatory Response Syndrome | 7 | 2021 | 6653 | 0.28 | Why? |
| Child | 21 | 2021 | 70012 | 0.28 | Why? |
| Viruses | 1 | 2018 | 2238 | 0.28 | Why? |
| Infant | 11 | 2021 | 30274 | 0.26 | Why? |
| Child, Preschool | 13 | 2021 | 36283 | 0.26 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.25 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.22 | Why? |
| Nurseries, Hospital | 1 | 2020 | 26 | 0.22 | Why? |
| Severity of Illness Index | 7 | 2021 | 48226 | 0.21 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.21 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.21 | Why? |
| Trichosporonosis | 1 | 2018 | 10 | 0.20 | Why? |
| Veillonella | 1 | 2018 | 8 | 0.19 | Why? |
| Rubulavirus | 1 | 2018 | 5 | 0.19 | Why? |
| Haemophilus | 1 | 2018 | 13 | 0.19 | Why? |
| Delivery Rooms | 1 | 2020 | 148 | 0.19 | Why? |
| Culture Techniques | 1 | 2018 | 36 | 0.19 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.19 | Why? |
| Pseudomonas | 1 | 2018 | 65 | 0.19 | Why? |
| Corynebacterium | 1 | 2018 | 47 | 0.18 | Why? |
| Streptococcus | 1 | 2018 | 76 | 0.18 | Why? |
| Dermatomycoses | 1 | 2018 | 55 | 0.18 | Why? |
| Adolescent | 15 | 2021 | 86841 | 0.18 | Why? |
| Respirovirus | 1 | 2018 | 122 | 0.18 | Why? |
| Hepatitis | 1 | 2020 | 160 | 0.18 | Why? |
| Staphylococcus | 1 | 2018 | 77 | 0.18 | Why? |
| Legionella | 1 | 2018 | 91 | 0.18 | Why? |
| Nursing Assessment | 1 | 2017 | 72 | 0.17 | Why? |
| Urinalysis | 1 | 2018 | 218 | 0.16 | Why? |
| Infant, Newborn | 5 | 2020 | 23105 | 0.16 | Why? |
| Hospitals, Pediatric | 3 | 2020 | 1792 | 0.15 | Why? |
| Surgical Wound Infection | 2 | 2018 | 501 | 0.15 | Why? |
| Metapneumovirus | 1 | 2018 | 465 | 0.15 | Why? |
| Paramyxoviridae Infections | 1 | 2018 | 364 | 0.15 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.14 | Why? |
| Fever | 3 | 2020 | 7795 | 0.14 | Why? |
| Child Welfare | 1 | 2020 | 405 | 0.14 | Why? |
| Antibiotic Prophylaxis | 1 | 2017 | 399 | 0.14 | Why? |
| Intensive Care Units, Neonatal | 1 | 2020 | 749 | 0.14 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 526 | 0.13 | Why? |
| Multiplex Polymerase Chain Reaction | 2 | 2018 | 1439 | 0.13 | Why? |
| Retrospective Studies | 12 | 2021 | 105322 | 0.12 | Why? |
| Aftercare | 1 | 2021 | 1637 | 0.11 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.11 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2018 | 846 | 0.11 | Why? |
| Young Adult | 6 | 2020 | 93724 | 0.10 | Why? |
| Bronchoscopy | 1 | 2018 | 991 | 0.10 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.10 | Why? |
| Pneumonia, Viral | 8 | 2021 | 243684 | 0.10 | Why? |
| Follow-Up Studies | 4 | 2021 | 17020 | 0.10 | Why? |
| Antimicrobial Stewardship | 1 | 2018 | 931 | 0.10 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.10 | Why? |
| Urologic Surgical Procedures | 1 | 2018 | 996 | 0.10 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2018 | 1234 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.09 | Why? |
| Humans | 27 | 2021 | 930598 | 0.08 | Why? |
| New York | 3 | 2021 | 2488 | 0.08 | Why? |
| Workload | 1 | 2017 | 1887 | 0.08 | Why? |
| Male | 16 | 2021 | 367725 | 0.08 | Why? |
| Female | 16 | 2021 | 380317 | 0.08 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Immunocompromised Host | 2 | 2021 | 5150 | 0.07 | Why? |
| Electronic Health Records | 1 | 2017 | 3492 | 0.07 | Why? |
| Nursing Staff, Hospital | 1 | 2017 | 1554 | 0.07 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.06 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.06 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.06 | Why? |
| Drug Approval | 2 | 2021 | 1325 | 0.06 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.06 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.05 | Why? |
| United States | 3 | 2021 | 46150 | 0.05 | Why? |
| Elective Surgical Procedures | 1 | 2017 | 5338 | 0.05 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.05 | Why? |
| National Institutes of Health (U.S.) | 1 | 2021 | 443 | 0.05 | Why? |
| Blood Sedimentation | 1 | 2020 | 508 | 0.04 | Why? |
| Stakeholder Participation | 1 | 2021 | 481 | 0.04 | Why? |
| Evidence-Based Medicine | 2 | 2021 | 3228 | 0.04 | Why? |
| Multiple Chronic Conditions | 1 | 2018 | 115 | 0.04 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Nausea | 1 | 2020 | 457 | 0.04 | Why? |
| Data Interpretation, Statistical | 1 | 2021 | 657 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.04 | Why? |
| Respiratory Insufficiency | 1 | 2018 | 7301 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Serum Albumin | 1 | 2020 | 571 | 0.04 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.04 | Why? |
| Diffusion of Innovation | 1 | 2020 | 440 | 0.04 | Why? |
| Syndrome | 1 | 2021 | 1310 | 0.04 | Why? |
| Seasons | 2 | 2018 | 4071 | 0.04 | Why? |
| Vomiting | 1 | 2020 | 722 | 0.04 | Why? |
| Abdominal Pain | 1 | 2020 | 858 | 0.03 | Why? |
| Liver Function Tests | 1 | 2020 | 1325 | 0.03 | Why? |
| Advisory Committees | 1 | 2021 | 1418 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2021 | 1276 | 0.03 | Why? |
| Interprofessional Relations | 1 | 2021 | 1013 | 0.03 | Why? |
| Visitors to Patients | 1 | 2020 | 671 | 0.03 | Why? |
| Patient Discharge | 2 | 2021 | 5696 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.03 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.03 | Why? |
| Respiration, Artificial | 1 | 2018 | 22116 | 0.03 | Why? |
| Lung | 1 | 2018 | 31049 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Personnel Staffing and Scheduling | 1 | 2017 | 1578 | 0.02 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Diarrhea | 1 | 2020 | 2743 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2018 | 13720 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.02 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Masks | 1 | 2020 | 8528 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Middle Aged | 2 | 2018 | 270681 | 0.01 | Why? |
| Coronavirus | 1 | 2018 | 18339 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.01 | Why? |
| Aged | 1 | 2018 | 215776 | 0.00 | Why? |
Zachariah's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(217)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_